India, Oct. 14 -- PharmEasy-Owned diagnostics laboratories chain Thyrocare's net profit surged 81% to INR 47.8 Cr in Q2 FY26 from INR 26.4 Cr in the year-ago quarter. On a sequential basis, the company's profit grew 25% from INR 38.3 Cr.

The sharp rise in the profit came on the back of a robust uptick in its top line and improvement in margins. The company's operating revenue stood at INR 216.5 Cr during the quarter under review, up 22% from INR 177.4 Cr in Q2 FY25. On a QoQ basis, revenue rose 12% from INR 193 Cr.

Including other income of INR 3.1 Cr, the company's total income for the quarter stood at INR 219.6 Cr. Meanwhile, its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr.

The company's board approved issuance of an inter...